Experts Look At How To Speed Approval Of Variant COVID-19 Vaccines
‘Global Forum’ Needed For Consensus On Requirements
Executive Summary
Senior members of three key regulatory and health bodies this week gave their assessments of the protection that existing COVID-19 vaccines may offer against future strains of the virus, and the requirements for developing and assessing modified vaccines.
You may also be interested in...
Coronavirus Notebook: EMA Explains How To Get A Modified Vaccine Approved, UK Starts Oxford/AZ Variant Vaccine Trial
Draft legislation on strengthening the European Medicines Agency’s role in health crises has cleared another hurdle, and the European Commission is inviting companies to a matchmaking event aimed at scaling up the development and production of COVID-19 therapeutics.
Real World Data on COVID-19 Vaccine Efficacy ‘Extremely Encouraging’
The effectiveness of coronavirus vaccines in preventing infection and symptomatic COVID-19 disease was explored at a virtual meeting held by the European Medicines Agency.
EU Explains Plans To Speed Up Variant Vaccine Approvals
The EU institutions are taking steps to preserve the effectiveness of existing vaccines in the face of mutations in the SARS-CoV-2 virus.